Extraintestinal Manifestations of Idiopathic Inflammatory Bowel Disease

Archives of Internal Medicine

Volumn 148, Issue 2, 1988, Pages 297-302

  Danzi, J Thomas ^a  

^a GUTHRIE RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTHRITIS; CHOLELITHIASIS; CROHN DISEASE; ENTERITIS; FEMALE; HUMAN; MALE; REVIEW; THROMBOEMBOLISM; ULCERATIVE COLITIS;

ARTHRITIS; BILIARY TRACT DISEASES; COLITIS, ULCERATIVE; CROHN DISEASE; EYE DISEASES; HUMAN; LIVER DISEASES; SKIN DISEASES; THROMBOPHLEBITIS;

EID: 0023835545     PISSN: 00039926     EISSN: 15383679     Source Type: Journal    
DOI: 10.1001/archinte.1988.00380020041008     Document Type: Article

References (42)

1. 1. Rankin GB, Watts HD, Melynk CS, et al: The National Cooperative Crohn’s Disease Study: Extraintestinal manifestations and perianal complications. Gastroenterology 1979;77:914-920.
2. 2. Greenstein AJ, Janowitz HD, Sachar DB: The extraintestinal complications of Crohn’s disease and ulcerative colitis. Medicine 1976;55:401-412.
3. 3. Garland CF, Lilienfield AM, Mendeloff AI, et al: Incidence rates of ulcerative colitis and Crohn’s disease in 15 areas of the United States. Gastroenterology 1981;81:1115-1124.
4. 4. Moll JM: Inflammatory bowel disease, in Panayi GS (ed): Clinics in Rheumatic Diseases. Philadelphia, WB Saunders Co, 1985, pp 87-105.
5. 5. Miclants H, Veys EM: HLA-B27 related arthritis and bowel inflammation: I. Sulfasalazine in HLA-B27 related reactive arthritis. J Rheumatol 1985;12:287-293.
6. 6. Kirsner JB, Shorter RG: Recent developments in ‘nonspecific’ inflammatory bowel disease: Part II. N Engl J Med 1982;306:837-848.
7. 7. Kirsner JB, Shorter RG: Recent developments in ‘nonspecific’ inflammatory bowel disease: Part I. N Engl J Med 1982;306:775-785.
8. 8. Fielding JF, Cooke WT: Finger clubbing and regional enteritis. Gut 1971;12:442-444.
9. 9. Farman J, Effmann EH, Grnja V: Crohn’s disease and periosteal new bone formation. Gastroenterology 1971;61:513-522.
10. 10. McCallum DI, Kinmont PD: Dermatological manifestations of Crohn’s disease. Br J Dermatol 1968;80:1-8.
11. 11. Mir-Madjlessi SH, Taylor, Farmer RG: Clinical course and evaluation of erythema nodosum and pyoderma gangrenosum in chronic ulcerative colitis: A study of 42 patients. Am J Gastroenterol 1985;80:615-620.
12. 12. Lever WF, Schaumburg-Lever G: Histolopathology of the Skin. Philadelphia, JB Lippincott, 1983, pp 246-256.
13. 13. Wolff K, Singl G: Pyoderma gangrenosum, in Fitzpatrick TB, Eisch AZ, Wolff K, et al (eds): Dermatology in General Practice. New York, McGraw-Hill International Book Co, 1983, pp 174-183.
14. 14. Spiro HM: Skin disease in ulcerative colitis, in Spiro HM (ed): Clinical Gastroenterology, ed 3. New York, Macmillan Publishing Co Inc, 1983, pp 951-952.
15. 15. Galan E, Flugelman MY, Rachmilewitz D: Pyoderma gangrenosum complicating ulcerative colitis: Successful treatment with methylprednisolone pulse therapy and dapsone. Am J Gastroenterol 1986;81:988-989.
16. 16. Wright R, Lumsden J, Luntz MH, et al: Abnormalities of the sacroiliac joints and uveitis. Q J Med 1965;34:229-236.
17. 17. Petrelli EA, McKinley M, Troncale FJ: Ocular manifestations of inflammatory bowel disease. Ann Ophthalmol 1982;14:356-360.
18. 18. Cello JP: Ulcerative colitis, in Sleisenger MH, Fordtran JS (eds): Gastrointestinal Disease, ed 3. Philadelphia, WB Saunders Co, 1983, pp 1122-1168.
19. 19. Kern F: Extraintestinal complications, in Kirsner J, Shorter JB (eds): Inflammatory Bowel Disease, ed 2. Philadelphia, Lea & Febiger, 1980, pp 217-240.
20. 20. Perrett AD: The liver in ulcerative colitis. Q J Med 1971;40:211-238.
21. 21. Wee A, Ludwig J: Pericholangitis in chronic ulcerative colitis: Primary sclerosing cholangitis of the small bile ducts. Ann Intern Med 1985;102:581-587.
22. 22. Cohen S: Liver disease and gallstones in regional enteritis. Gastroenterology 1971;60:237-245.
23. 23. LaRusso NF, Weisner RH, Ludwig J, et al: Primary sclerosing cholangitis. N Engl J Med 1984;310:899-903.
24. 24. Weisner RH, LaRusso NF: Clinicopathological features of the syndrome of primary sclerosing cholangitis. Gastroenterology 1980;79:200-206.
25. 25. Bodenheimer HC Jr, LaRusso NF, Thayer WR Jr, et al: Elevated circulating immune complexes in primary sclerosing cholangitis. Hepatology 1983;3:150-154.
26. 26. Gross JB Jr, Beaver SJ, McCall JT, et al: Abnormalities in tests of copper metabolism in primary sclerosing cholangitis: Prognostic and diagnostic significance, abstracted. Gastroenterology 1983;84:1176.
27. 27. Keefe EB: Primary sclerosing cholangitis in ulcerative colitis. Ann Intern Med 1985;103:305-306.
28. 28. Tobias R, Wright JP, Kottler RE, et al: Primary sclerosing cholangitis associated with inflammatory bowel disease. S Afr Med J 1983;63:229-235.
29. 29. Sivak MV Jr, Farmer RG, Lalli AF: Sclerosing cholangitis: Its increasing frequency of recognition and association with inflammatory bowel disease. J Clin Gastroenterol 1981;3:261-266.
30. 30. Kaplan MM, Sanjeev A, Pincus SH: Primary sclerosing cholangitis and low-dose oral pulse methotrexate therapy. Ann Intern Med 1987;106:231-235.
31. 31. Johnson GK, Geenan JE, Venu RP, et al: Endoscopic treatment of biliary duct strictures in sclerosing cholangitis: Follow-up assessment of a new therapeutic approach. Gastrointest Endosc 1987;33:9-12.
32. 32. Soloway RD, Summerskill WHJ, Baggenstoss AH, et al: Clinical, biochemical, and histological remission of severe chronic active liver disease: A controlled study of treatment and early prognosis. Gastroenterology 1972;63:820-833.
33. 33. Sherlock S, Redeker AG, Seef LB, et al: Treat or don’t treat asymptomatic chronic active hepatitis: Three opinions. Pract Gastroenterol 1978;2:30-36.
34. 34. Akwari OE, Van Heerden JA, Joulk WT, et al: Cancer of the bile ducts associated with ulcerative colitis. Ann Surg 1975;181:303-309.
35. 35. Wee A, Ludwig J, Coffey RJ, et al: Hepatobiliary carcinoma associated with primary sclerosing cholangitis and chronic ulcerative colitis. Hum Pathol 1985;16:719-726.
36. 36. Danzi JT, Makipour H, Farmer RG: Primary sclerosing cholangitis. Am J Gastroenterol 1976;65:109-116.
37. 37. Peppersorn JT: Sulfasalazine. Ann Intern Med 1984;101:377-386.
38. 38. Fitchen JH: Amyloidosis and granulomatous ileocolitis: Regression after surgical removal of the involved bowel. N Engl J Med 1975;292:352-353.
39. 39. Graef v, Baggenstoss AH, Sauer WG, et al: Venous thrombosis occurring in nonspecific ulcerative colitis: A necropsy study. Arch Intern Med 1966;117:377-382.
40. 40. Talbot RW, Heppell J, Dozois RR, et al: Vascular complications of inflammatory bowel disease. Mayo Clin Proc 1986;61:140-145.
41. 41. Patwardhan RV Heilpern J, Brewster AC, et al: Pleuropericarditis: An extraintestinal complication of inflammatory bowel disease. Arch Intern Med 1983;143:94-96.
42. 42. Smith LH, Fromm H, Hofmann AF: Acquired hyperoxaluria, nephrolithiasis, and intestinal disease: Description of a syndrome. N Engl J Med 1972;286:1371-1375.